IL-20 targeting mAbs (National Cheng Kung University)

N/A

Report date: 2025/03/20 16:02:48

Base Information

Drug NameIL-20 targeting mAbs (National Cheng Kung University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin 20 inhibitors
TargetsInterleukin 20
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Cheng Kung University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A